Representing Israel at the 2013 International TedMed Conference, which showcases innovations in medical and biotechnology, Dr. Itai Berger, Director of the Hadassah Medical Center’s Neuro-Cognitive Center, presented Hadassah’s model for treating attention deficit hyperactivity disorder (ADHD).

This is the first year that Israel has sent a delegation to the TedMed conference. More than 2,000 organizations and individuals applied to participate in this year’s conference and only 20 delegates were chosen. Dr. Berger participated in what is known as “The Great Challenge Day” of the Conference, which features discussion groups devoted to particular specialties. Dr. Berger’s group was entitled “Faster Adoption of Best Practices.” He reports that his presentation was well received.